Loading clinical trials...
Loading clinical trials...
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of ASA404 in Adult Cancer Patients With Impaired Hepatic Function and With Normal Hepatic Function
Conditions
Interventions
ASA404
Locations
4
Italy
Novartis Investigative Site
Ancona, AN, Italy
Novartis Investigative Site
Milan, Italy
Novarts Investigative Site
Auckland, New Zealand
Novartis Investigative Site
Wellington, New Zealand
Start Date
January 1, 2010
Primary Completion Date
November 1, 2010
Last Updated
December 9, 2020
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions